Adenovirus Mediated Endothelial Nitric Oxide Synthase Gene Transfer Prevents Restenosis of Vein Grafts

ASAIO Journal

Volumn 50, Issue 3, 2004, Pages 272-277

  Wu, Shuming ^a,c   Wang, Xiaoming ^b   Guo, Lanmin ^a   Zi, Jie ^a  

^a SHANDONG UNIVERSITY   (China)

^b Provincial Hospital   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOLOGY; NITROGEN OXIDES; VECTORS;

ADENOVIRAL VECTORS; VEIN GRAFTS;

GENE TRANSFER;

ADENOVIRUS VECTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; GENE TRANSFER; GOAT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; JUGULAR VEIN; NONHUMAN; PROTEIN EXPRESSION; RESTENOSIS; TRANSGENE; VASCULAR PATENCY; VEIN GRAFT;

ADENOVIRIDAE; ANIMALS; ARTERIOVENOUS ANASTOMOSIS; CAROTID ARTERIES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GOATS; GRAFT OCCLUSION, VASCULAR; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; JUGULAR VEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSGENES; TRANSPLANTS;

EID: 2342602912     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000124842.79638.CE     Document Type: Article

References (26)

1. Grondin CM, Lesperance J, Bourassa MG, Pasternac A, Campneau L, Grondin P: Serial angiographic evaluation in 60 consecutive patients with aortocoronary artery vein grafts 2 weeks, 1 year and 3 years after operation. J Thorac Cardiovasc Surg 67: 1-6, 1974.
2. FitzGibbon GM, Leach AJ, Keon WJ, Burton JR, Kafka HP: Coronary bypass grafts fate: Angiographic study of 1,179 vein grafts early, one year, and five years after operation. J Thorac Cardiovasc Surg 91: 773-778, 1986.
3. Grondin CM, Campeau L, Lesperance J, et al: Atheroscierotic changes in coronary vein grafts six years after operation: angiographic aspect in 110 patients. J Thorac Cardiovasc Surg 77: 24-31, 1979.
4. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84: 9265-9269, 1987.
5. Radomski MW, Palmer RM, Moncada S: The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92: 639-646, 1987.
6. Radomski MW, Palmer RM, Moncada S: Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92: 181-187, 1987.
7. Schafer AL, Alexander RW, Handin RI: Inhibition of platelet function by organic nitrate vasodilators. Blood 55: 649-654, 1980.
8. Vassalli G, Dichek DA: Gene therapy for arterial thrombosis. Cardiovasc Res 35: 459-469, 1997.
9. Ng P, Parks RJ, Cummings DT, Evelegh CM, Sankar U, Graham FL: A high-efficiency Cre/loxP-based system for construction of adenoviral vectors. Hum Gene Ther 10: 2667-2672, 1999.
10. Graham FL, Smiley J, Russell WC, Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74, 1977.
11. Jelinek T, Graham FL: Recombinant human adenoviruses containing hybrid adenovirus type 5 (Ad5)/Ad12 E1A genes: characterization of hybrid E1A proteins and analysis of transforming activity and host range. J Virol 66: 4117-4125, 1992.
12. Hirt B: Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26: 365-369, 1967.
13. Cable DG, O'Brien T, Schaff HV, Pȯmpili VJ: Recombinant endothelial nitric oxide synthase-transduced human saphenous veins gene therapy to augment nitric oxide production in bypass conduits. Circulation 96: 173-178, 1997.
14. Janssens S, Flaherty D, Nong Z, et al: Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 97: 1274-1281, 1998.
15. Archer S: Measurement of nitric oxide in biological models. FASEB J 7: 349-360, 1993.
16. Rosselli M, Imthurm B, Macas E, Keller PJ, Dubey RK: Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO release. Biochem Biophys Res Commun 202: 1543-1552, 1994.
17. Knowles TG, Moncada S: Nitric oxide synthases in mammals. Biochem J 298(pt 2): 249-258, 1994.
18. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
19. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC: Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78: 225-230, 1996.
20. Malik N, Francis SE, Holt CM, et al: Apoptosis and cell proliferation after porcine coronary angioplasty. Circulation 98: 1657-1665, 1998.
21. Pollman C, Yamada T, Horiuchi M, Gibbons G: Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 79: 748-756, 1996.
22. Sato JI, Nair K, Hiddinga J, et al: eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovas Res 47: 697-706, 2000.
23. von der Leyen HE, Gibbons GH, Morishita R, et al: Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial nitric oxide synthase gene. Proc Natl Acad Sci U S A 92: 1137-1141, 1995.
24. Kullo IJ, Mozes G, Schwartz RS, et al: Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. Hypertension 30: 314-320, 1997.
25. Cable DG, O'Brien T, Kullo IJ, Schwartz RS, Schaff HV, Pompili VJ: Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries. Cardiovasc Res 35: 553-559, 1997.
26. Yi S, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A: Adventitial remodeling after coronary arterial injury. Circulation 93: 340-348, 1996.